Mónica Cabrero

1.1k total citations
33 papers, 558 citations indexed

About

Mónica Cabrero is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Mónica Cabrero has authored 33 papers receiving a total of 558 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hematology, 7 papers in Molecular Biology and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Mónica Cabrero's work include Acute Myeloid Leukemia Research (16 papers), Hematopoietic Stem Cell Transplantation (9 papers) and Acute Lymphoblastic Leukemia research (6 papers). Mónica Cabrero is often cited by papers focused on Acute Myeloid Leukemia Research (16 papers), Hematopoietic Stem Cell Transplantation (9 papers) and Acute Lymphoblastic Leukemia research (6 papers). Mónica Cabrero collaborates with scholars based in Spain, United States and Canada. Mónica Cabrero's co-authors include Guillermo Garcia‐Manero, Zach Bohannan, Hui Yang, Simona Colla, Yue Wei, Irene Gañán‐Gómez, Ulrich Steidl, Amit Verma, Daniel T. Starczynowski and Lourdes Vázquez and has published in prestigious journals such as Blood, Clinical Cancer Research and Leukemia.

In The Last Decade

Mónica Cabrero

30 papers receiving 551 citations

Peers

Mónica Cabrero
Tsuyoshi Takahashi Japan
Kang Howson‐Jan Canada
P Anderlini United States
Janet Hayden United Kingdom
D Samson United Kingdom
T de Witte Netherlands
S. Giralt United States
Anastasia Athanasiadou Greece
MR Litzow United States
A. R. Zander Germany
Tsuyoshi Takahashi Japan
Mónica Cabrero
Citations per year, relative to Mónica Cabrero Mónica Cabrero (= 1×) peers Tsuyoshi Takahashi

Countries citing papers authored by Mónica Cabrero

Since Specialization
Citations

This map shows the geographic impact of Mónica Cabrero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mónica Cabrero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mónica Cabrero more than expected).

Fields of papers citing papers by Mónica Cabrero

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mónica Cabrero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mónica Cabrero. The network helps show where Mónica Cabrero may publish in the future.

Co-authorship network of co-authors of Mónica Cabrero

This figure shows the co-authorship network connecting the top 25 collaborators of Mónica Cabrero. A scholar is included among the top collaborators of Mónica Cabrero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mónica Cabrero. Mónica Cabrero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mora, Elvira, Juan Montoro, Aitana Balaguer‐Roselló, et al.. (2024). Total body irradiation versus thiotepa/busulfan-based conditioning regimens for myeloablative allogeneic stem cell transplantation in adults with acute lymphoblastic leukemia. Bone Marrow Transplantation. 59(8). 1137–1145. 1 indexed citations
2.
Cabrero, Mónica, Lucía López‐Corral, Isidro Jarque, et al.. (2024). Ofatumumab as part of reduced intensity conditioning in high risk B-cell lymphoma patients: final long-term analysis from a prospective multicenter Phase-II Trial. Bone Marrow Transplantation. 59(3). 359–365. 1 indexed citations
3.
Sánchez‐Guijo, Fermín, Lucía López‐Corral, Mónica Baile, et al.. (2020). Measures to Maintain a SARS-CoV-2 Negative Inpatient Hematological Unit in the Midst of the COVID-19 Pandemic. Frontiers in Medicine. 7. 462–462. 1 indexed citations
4.
Martı́n, Alejandro, et al.. (2017). 18 F-FDG PET/TC en el manejo clínico de los linfomas. Revista Española de Medicina Nuclear e Imagen Molecular. 36(5). 312–321. 5 indexed citations
5.
Chamseddine, Ali N., Mónica Cabrero, Yue Wei, et al.. (2016). PDE4 Differential Expression Is a Potential Prognostic Factor and Therapeutic Target in Patients With Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia. Clinical Lymphoma Myeloma & Leukemia. 16. S67–S73. 6 indexed citations
6.
7.
Kekre, Natasha, Francisco J. Márquez‐Malaver, Mónica Cabrero, et al.. (2016). Fludarabine/Busulfan versus Fludarabine/Melphalan Conditioning in Patients Undergoing Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation for Lymphoma. Biology of Blood and Marrow Transplantation. 22(10). 1808–1815. 19 indexed citations
8.
Cabrero, Mónica, Yue Wei, Hui Yang, et al.. (2016). Down-regulation of EZH2 expression in myelodysplastic syndromes. Leukemia Research. 44. 1–7. 13 indexed citations
9.
Yang, Hui, Andres Quesada, Zachary S. Bohannan, et al.. (2015). Analysis of class I and II histone deacetylase gene expression in human leukemia. Leukemia & lymphoma. 56(12). 3426–3433. 19 indexed citations
10.
Gañán‐Gómez, Irene, Yue Wei, Daniel T. Starczynowski, et al.. (2015). Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes. Leukemia. 29(7). 1458–1469. 176 indexed citations
11.
Bastida, José María, Mónica Cabrero, Oriana López‐Godino, et al.. (2015). Influence of donor age in allogeneic stem cell transplant outcome in acute myeloid leukemia and myelodisplastic syndrome. Leukemia Research. 39(8). 828–834. 31 indexed citations
12.
13.
Badar, Talha, Keyur P. Patel, Philip A. Thompson, et al.. (2015). Detectable FLT3-ITD or RAS mutation at the time of transformation from MDS to AML predicts for very poor outcomes. Leukemia Research. 39(12). 1367–1374. 39 indexed citations
14.
Garcia‐Manero, Guillermo, H. Jean Khoury, Elias Jabbour, et al.. (2014). A Phase I Study of Oral ARRY-614, a p38 MAPK/Tie2 Dual Inhibitor, in Patients with Low or Intermediate-1 Risk Myelodysplastic Syndromes. Clinical Cancer Research. 21(5). 985–994. 40 indexed citations
15.
Alonso, Sara, Julio Dávila, Mónica Cabrero, et al.. (2014). Late Differentiation Syndrome in Acute Promyelocytic Leukemia: A Challenging Diagnosis. Hematology Reports. 6(4). 5654–5654. 3 indexed citations
16.
Labrador, Jorge, Lucía López‐Corral, Oriana López‐Godino, et al.. (2014). Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus. Bone Marrow Transplantation. 49(5). 684–690. 39 indexed citations
17.
Labrador, Jorge, Mónica Cabrero, María‐Victoria Mateos, et al.. (2014). ESHAP as salvage therapy for relapsed or refractory Hodgkin’s lymphoma. Annals of Hematology. 93(10). 1745–1753. 30 indexed citations
18.
Reinoso, Roberto, Ester Carreño, Denise Hileeto, et al.. (2013). Fatal disseminated Scedosporium prolificans infection initiated by ophthalmic involvement in a patient with acute myeloblastic leukemia. Diagnostic Microbiology and Infectious Disease. 76(3). 375–378. 8 indexed citations
19.
López‐Corral, Lucía, et al.. (2012). Efecto de injerto contra tumor. 13(3). 89–93. 1 indexed citations
20.
Pérez-Simón, Josè Antonio, Rodrigo Martino, Rocío Parody, et al.. (2012). The combination of sirolimus plus tacrolimus improves outcome after reduced-intensity conditioning, unrelated donor hematopoietic stem cell transplantation compared with cyclosporine plus mycofenolate. Haematologica. 98(4). 526–532. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tsuyoshi Takahashi Breakdown of academic impact, for papers by Kang Howson‐Jan Breakdown of academic impact, for papers by P Anderlini Breakdown of academic impact, for papers by Janet Hayden Breakdown of academic impact, for papers by D Samson Breakdown of academic impact, for papers by T de Witte Breakdown of academic impact, for papers by S. Giralt Breakdown of academic impact, for papers by Anastasia Athanasiadou Breakdown of academic impact, for papers by MR Litzow Breakdown of academic impact, for papers by A. R. Zander
Rankless by CCL
2026